Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Insulin Lispro 100 UNT/ML
DRUG
3 trials
Sponsors
Diasome Pharmaceuticals
, Centre for Addiction and Mental Health
Conditions
Antipsychotics
Diabetes Mellitus, Type 1
Healthy Controls
Insulin Resistance
Menstrual Cycle
Type 2 Diabetes
Phase 1
Intranasal Insulin and Olanzapine Study in Healthy Volunteers
NCT03741478
Centre for Addiction and Mental Health
Healthy Controls
Start: 2019-10-22
End: 2024-07-30
Target: 64
Updated: 2023-07-17
Phase 2
Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control
Completed
NCT03096392
Diasome Pharmaceuticals
Diabetes Mellitus, Type 1
Start: 2017-04-18
End: 2018-03-18
Updated: 2018-07-31
Unknown Phase
Effects of Antipsychotics on Brain Insulin Action in Females
Recruiting
NCT06251635
Centre for Addiction and Mental Health
Antipsychotics, Insulin Resistance, Menstrual Cycle +1
Start: 2024-06-03
End: 2026-08-01
Target: 15
Updated: 2026-03-31
Related Papers
Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls
PLoS ONE
2022-11-28
2 citations